GSK Raises Guidance After Sales, Earnings Growth

Core Viewpoint - The drugmaker has revised its sales growth expectations for 2025, now forecasting an increase of 6% to 7% when excluding currency movements, an improvement from the previous estimate of 3% to 5% [1] Summary by Category - Sales Growth Expectations - The company anticipates a sales growth of 6% to 7% for 2025, excluding the impact of currency fluctuations [1] - This is a notable increase from the earlier forecast range of 3% to 5% [1]